Cognition Therapeutics
(NASDAQ) CGTX
Cognition Therapeutics Financials at a Glance
Market Cap
$77.56M
Revenue (TTM)
$0.00
Net Income (TTM)
$23.49M
EPS (TTM)
$-0.34
P/E Ratio
-2.53
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.88
Volume
15,025
Open
$0.83
Price
$0.88
Volume
15,025
Open
$0.83
Previous Close
$0.88
Daily Range
$0.83 - $0.88
52-Week Range
$0.22 - $3.83
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.88
Volume
15,025
Open
$0.83
Previous Close
$0.88
Daily Range
$0.83 - $0.88
52-Week Range
$0.22 - $3.83
CGTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cognition Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
14
CEO
Lisa R. Ricciardi, MBA
Website
www.cogrx.comHeadquarters
Purchase, NY 10577, US
CGTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-89%
Return on Capital
-1%
Return on Assets
-49%
Earnings Yield
-39.53%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$77.56M
Shares Outstanding
89.35M
Volume
15.03K
Short Interest
0.00%
Avg. Volume
1.06M
Financials (TTM)
Gross Profit
$228.00K
Operating Income
$47.80M
EBITDA
$47.80M
Operating Cash Flow
$24.59M
Capital Expenditure
$0.00
Free Cash Flow
$24.59M
Cash & ST Invst.
$36.81M
Total Debt
$638.00K
Cognition Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$61.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$77.56M
N/A
Market Cap/Employee
$3.10M
N/A
Employees
25
N/A
Net Income
$3.34M
+57.4%
EBITDA
$13.61M
-75.3%
Quarterly Fundamentals
Net Cash
$36.36M
+50.3%
Accounts Receivable
$9.92M
+269.4%
Inventory
$0.00
N/A
Long Term Debt
$195.00K
-43.0%
Short Term Debt
$443.00K
-6.1%
Return on Assets
-48.54%
N/A
Return on Invested Capital
-1.39%
N/A
Free Cash Flow
$3.44M
+59.0%
Operating Cash Flow
$3.44M
+59.0%